Mark Dolev

52 papers receiving 1.4k citations

Mark Dolev's Hit Papers

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies 2021 · 236 citations
2360+1+3Years since publication50100150200

Peers

Mark Dolev
Comparison fields: 5 of 88
  • Pathology and Forensic Medicine 866
  • Neurology 235
  • Infectious Diseases 276
  • Immunology 181
  • Physical Therapy, Sports Therapy and Rehabilitation 36
Replace David Magalashvili with:
David Magalashvili Israel
Gabriel Pardo United States
Yael Stern Israel
Naraporn Prayoonwiwat Thailand
David Ellenberger Germany
Christopher McGuigan Ireland
Naila Makhani United States
Mari Smith United States
Abdorreza Naser Moghadasi Iran
Jonathan Howard United States
Mark Dolev relative to David Magalashvili Israel David Magalashvili's profile →
Citations per field
00.5×4.5×
David Magalashvili · 1×
Citations per year

Countries citing papers authored by Mark Dolev

Since Specialization
Citations

This map shows the geographic impact of Mark Dolev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dolev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dolev more than expected).

Fields of papers citing papers by Mark Dolev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Dolev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dolev. The network helps show where Mark Dolev may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Dolev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Dolev Line = papers co-authored together Mark Dolev links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Hit paper breakdown →
2021236
2 2021147
3 2004142
4 2013119
5 200474
6 201461
7 202158
8 201753
9 202240
10 201035
11 202032
12 200028
13 201528
14 201627
15 202227
16 200422
17 201220
18
Multiple sclerosis in Israeli children: incidence, an clinical, cerebrospinal fluid and magnetic resonance imaging findings.
201219
19 202117
20 201916

About Mark Dolev

Mark Dolev is a scholar working on Pathology and Forensic Medicine, Infectious Diseases, Hematology, Oncology and Immunology, having authored 52 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (32 papers), Autoimmune and Inflammatory Disorders Research (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Peripheral Neuropathies and Disorders (3 papers), Polyomavirus and related diseases (2 papers), Pain Mechanisms and Treatments (2 papers), Effects of Vibration on Health (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (866 citations), Neurology (235 citations), Infectious Diseases (276 citations), Immunology (181 citations) and Physical Therapy, Sports Therapy and Rehabilitation (36 citations). Mark Dolev has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Anat Achiron, David Magalashvili, Shay Menascu, Michael Gurevich, Yael Stern, Uri Givon, Alon Kalron, Sapir Dreyer-Alster, Gil Harari and Shlomo Flechter. Their work appears in journals such as PLoS ONE, Multiple Sclerosis and Related Disorders, Therapeutic Advances in Neurological Disorders, Journal of Neurology and Multiple Sclerosis Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact